01513.HK
Livzon Pharmaceutical Group, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 20.40
−1.16%Forward multiples
Based on analyst estimates
- P/E forward
- 17.09x
- P/E 2026E
- 7.85x
- P/E 2027E
- 7.21x
- P/E 2028E
- 6.67x
- P/S forward
- 2.93x
Trailing multiples
Trailing twelve months
- P/E TTM
- 9.23x
- PEG TTM
- 2.10x
- Price / book
- 1.16x
- Price / sales
- 1.45x
- Price / cash flow
- 4.69x
Enterprise value
- Enterprise value
- HKD 14.9B
- EV / sales
- 1.19x
- EV / EBITDA
- 4.72x
- EV / EBIT
- 5.57x
- Market cap
- HKD 18.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026